Skip to main content
Top
Published in: Respiratory Research 1/2017

Open Access 01-12-2017 | Research

An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation

Authors: Paul E. Pfeffer, Susan Hopkins, Ian Cropley, David M. Lowe, Marc Lipman

Published in: Respiratory Research | Issue 1/2017

Login to get access

Abstract

Background

The rising incidence of pulmonary Mycobacterium avium-intracellulare complex (MAI) infection is unexplained but parallels the growing world-wide epidemic of allergic disease. We hypothesized an association between pulmonary MAI infection and Th2-type immune responses as seen in allergy.

Methods

Biomarkers of patient Th2-type immune responses (peripheral blood eosinophil counts and serum IgE levels) were compared between patients with positive pulmonary samples for tuberculosis and non-tuberculous mycobacterial (NTM) infection. A further comparison of clinical characteristics, including respiratory co-morbidities, and biomarkers, was conducted between patients culturing MAI NTM and those culturing NTM other than MAI.

Results

Patients culturing NTM from pulmonary samples had significantly higher peripheral blood eosinophil levels than those culturing Mycobacterium tuberculosis. Furthermore, patients culturing MAI compared to those culturing NTM other than MAI had higher eosinophil counts (mean 0.29x109/L vs 0.15x109/L, p = 0.010) and IgE levels (geometric mean 138kU/L vs 47kU/L, p = 0.021). However there was no significant difference in the frequency of asthma between the two NTM groups.

Conclusions

There is an association between biomarkers of Th2-type immune responses and pulmonary MAI. Prospective and translational research could identify the direction of causation; and so determine whether our finding may be utilized within future management strategies for MAI.
Literature
1.
go back to reference Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34:87–94.CrossRefPubMed Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34:87–94.CrossRefPubMed
2.
go back to reference Shah NM, Davidson JA, Anderson LF, Lalor MK, Kim J, Thomas HL, et al. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non- tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007–2012. BMC Inf Dis. 2016;16:195.CrossRef Shah NM, Davidson JA, Anderson LF, Lalor MK, Kim J, Thomas HL, et al. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non- tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007–2012. BMC Inf Dis. 2016;16:195.CrossRef
3.
go back to reference Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med. 2011;105:1718–25.CrossRefPubMed Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med. 2011;105:1718–25.CrossRefPubMed
4.
go back to reference Yeung MW, Khoo E, Brode SK, Jamieson FB, Kamiya H, Kwong JC, et al. Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review. Respirology. 2016;21:1015–25.CrossRefPubMed Yeung MW, Khoo E, Brode SK, Jamieson FB, Kamiya H, Kwong JC, et al. Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review. Respirology. 2016;21:1015–25.CrossRefPubMed
5.
go back to reference Xu HB, Jiang RH, Li L. Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2014;33:347–58.CrossRefPubMed Xu HB, Jiang RH, Li L. Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2014;33:347–58.CrossRefPubMed
6.
go back to reference Griffith DE. Risk-benefit assessment of therapies for Mycobacterium avium complex infections. Drug Saf. 1999;21:137–52.CrossRefPubMed Griffith DE. Risk-benefit assessment of therapies for Mycobacterium avium complex infections. Drug Saf. 1999;21:137–52.CrossRefPubMed
7.
go back to reference Wu U-I, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;15:968–80.CrossRefPubMed Wu U-I, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;15:968–80.CrossRefPubMed
8.
go back to reference Lake MA, Ambrose LR, Lipman MC, Lowe DM. “Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med. 2016;14:54.CrossRefPubMedPubMedCentral Lake MA, Ambrose LR, Lipman MC, Lowe DM. “Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med. 2016;14:54.CrossRefPubMedPubMedCentral
9.
go back to reference Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J. 2005;25:324–8.CrossRefPubMed Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J. 2005;25:324–8.CrossRefPubMed
10.
go back to reference Andrejak C, Nielsen R, Thomsen V, Duhaut P, Sorensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68:256–62.CrossRefPubMed Andrejak C, Nielsen R, Thomsen V, Duhaut P, Sorensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68:256–62.CrossRefPubMed
11.
go back to reference Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J. 2008;31:1322–33.CrossRefPubMed Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J. 2008;31:1322–33.CrossRefPubMed
13.
go back to reference Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62:758–66.CrossRefPubMedPubMedCentral Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62:758–66.CrossRefPubMedPubMedCentral
14.
15.
go back to reference Durham SR, Till SJ, Corrigan CJ. T lymphocytes in asthma: Bronchial versus peripheral responses. J Allergy Clin Immunol. 2000;106:S221–6.CrossRefPubMed Durham SR, Till SJ, Corrigan CJ. T lymphocytes in asthma: Bronchial versus peripheral responses. J Allergy Clin Immunol. 2000;106:S221–6.CrossRefPubMed
16.
go back to reference Juhn YJ. Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease? J Allergy Clin Immunol. 2014;134:247–57.CrossRefPubMedPubMedCentral Juhn YJ. Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease? J Allergy Clin Immunol. 2014;134:247–57.CrossRefPubMedPubMedCentral
17.
go back to reference Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, Roberg KA, et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med. 2012;185:1275–9.CrossRefPubMedPubMedCentral Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, Roberg KA, et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med. 2012;185:1275–9.CrossRefPubMedPubMedCentral
18.
go back to reference Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352:2082–90.CrossRefPubMed Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352:2082–90.CrossRefPubMed
19.
go back to reference Traynor TR, Kuziel WA, Toews GB, Huffnagle GB. CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection. J Immunol. 2000;164:2021–7.CrossRefPubMed Traynor TR, Kuziel WA, Toews GB, Huffnagle GB. CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection. J Immunol. 2000;164:2021–7.CrossRefPubMed
20.
go back to reference Pfeffer PE, Sen A, Das S, Sheaff M, Sivaramakrishnan A, Simcock DE, et al. Eosinophilia, meningitis and pulmonary nodules in a young woman. Thorax. 2010;65:1066,1085.CrossRefPubMed Pfeffer PE, Sen A, Das S, Sheaff M, Sivaramakrishnan A, Simcock DE, et al. Eosinophilia, meningitis and pulmonary nodules in a young woman. Thorax. 2010;65:1066,1085.CrossRefPubMed
21.
go back to reference Peng JK, Lin JS, Kung JT, Finkelman FD, Wu-Hsieh BA. The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection. Int Immunol. 2005;17:193–205.CrossRefPubMed Peng JK, Lin JS, Kung JT, Finkelman FD, Wu-Hsieh BA. The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection. Int Immunol. 2005;17:193–205.CrossRefPubMed
22.
go back to reference Westerhof GA, Korevaar DA, Amelink M, de Nijs SB, de Groot JC, Wang J, et al. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes. Eur Respir J. 2015;46:688–96.CrossRefPubMed Westerhof GA, Korevaar DA, Amelink M, de Nijs SB, de Groot JC, Wang J, et al. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes. Eur Respir J. 2015;46:688–96.CrossRefPubMed
23.
go back to reference Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70:115–20.CrossRefPubMed Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70:115–20.CrossRefPubMed
24.
go back to reference Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol. 2009;21:1303–9.CrossRefPubMed Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol. 2009;21:1303–9.CrossRefPubMed
25.
go back to reference Bacharier LB, Geha RS. Molecular mechanisms of IgE regulation. J Allergy Clin Immunol. 2000;105:S547–558.CrossRefPubMed Bacharier LB, Geha RS. Molecular mechanisms of IgE regulation. J Allergy Clin Immunol. 2000;105:S547–558.CrossRefPubMed
26.
go back to reference Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180:388–95.CrossRefPubMedPubMedCentral Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180:388–95.CrossRefPubMedPubMedCentral
27.
go back to reference Aksamit TR, O’Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels ML, et al. Adult Bronchiectasis Patients: A First Look at the United States Bronchiectasis Research Registry. Chest. 2016. doi:10.1016/j.chest.2016.10.055 [Epub ahead of print]. Aksamit TR, O’Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels ML, et al. Adult Bronchiectasis Patients: A First Look at the United States Bronchiectasis Research Registry. Chest. 2016. doi:10.​1016/​j.​chest.​2016.​10.​055 [Epub ahead of print].
28.
go back to reference Wang D, Luo J, Du W, Zhang LL, He LX, Liu CT. A morphologic study of the airway structure abnormalities in patients with asthma by high-resolution computed tomography. J Thorac Dis. 2016;8:2697–708.CrossRefPubMedPubMedCentral Wang D, Luo J, Du W, Zhang LL, He LX, Liu CT. A morphologic study of the airway structure abnormalities in patients with asthma by high-resolution computed tomography. J Thorac Dis. 2016;8:2697–708.CrossRefPubMedPubMedCentral
29.
go back to reference Pavord ID, Agusti A. Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease. Eur Respir J. 2016;47:1299–303.CrossRefPubMed Pavord ID, Agusti A. Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease. Eur Respir J. 2016;47:1299–303.CrossRefPubMed
31.
go back to reference Jasenosky LD, Scriba TJ, Hanekom WA, Goldfeld AE. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev. 2015;264:74–87.CrossRefPubMed Jasenosky LD, Scriba TJ, Hanekom WA, Goldfeld AE. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev. 2015;264:74–87.CrossRefPubMed
33.
go back to reference O’Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol. 1994;6:458–66.CrossRefPubMed O’Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol. 1994;6:458–66.CrossRefPubMed
34.
go back to reference Cohn L, Herrick C, Niu N, Homer RJ, Bottomly K. IL-4 Promotes Airway Eosinophilia by Suppressing IFN-γ Production. Defining a Novel Role for IFN-γ in the Regulation of Allergic Airway Inflammation. J Immunol. 2001;166:2760–7.CrossRefPubMed Cohn L, Herrick C, Niu N, Homer RJ, Bottomly K. IL-4 Promotes Airway Eosinophilia by Suppressing IFN-γ Production. Defining a Novel Role for IFN-γ in the Regulation of Allergic Airway Inflammation. J Immunol. 2001;166:2760–7.CrossRefPubMed
35.
go back to reference Contoli M, Ito K, Padovani A, Poletti D, Marku B, Edwards MR, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy. 2015;70:910–20.CrossRefPubMed Contoli M, Ito K, Padovani A, Poletti D, Marku B, Edwards MR, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy. 2015;70:910–20.CrossRefPubMed
36.
go back to reference Hatchwell L, Collison A, Girkin J, Parsons K, Li J, Zhang J, et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax. 2015;70:854–61.CrossRefPubMedPubMedCentral Hatchwell L, Collison A, Girkin J, Parsons K, Li J, Zhang J, et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax. 2015;70:854–61.CrossRefPubMedPubMedCentral
37.
go back to reference Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-Linked Agammaglobulinemia. Report on a United States Registry of 201 Patients. Medicine (Baltimore). 2006;85:193–202.CrossRef Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-Linked Agammaglobulinemia. Report on a United States Registry of 201 Patients. Medicine (Baltimore). 2006;85:193–202.CrossRef
38.
go back to reference Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 Patients with Common Variable Immunodeficiency. Clin Infect Dis. 2008;46:1547–54.CrossRefPubMed Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 Patients with Common Variable Immunodeficiency. Clin Infect Dis. 2008;46:1547–54.CrossRefPubMed
39.
go back to reference Shirey KA, Cole LE, Keegan AD, Vogel SN. Francisella tularensis Live Vaccine Strain Induces Macrophage Alternative Activation as a Survival Mechanism. J Immunol. 2008;181:4159–67.CrossRefPubMedPubMedCentral Shirey KA, Cole LE, Keegan AD, Vogel SN. Francisella tularensis Live Vaccine Strain Induces Macrophage Alternative Activation as a Survival Mechanism. J Immunol. 2008;181:4159–67.CrossRefPubMedPubMedCentral
40.
go back to reference Parker W. The “hygiene hypothesis” for allergic disease is a misnomer. BMJ. 2014;26:g5267.CrossRef Parker W. The “hygiene hypothesis” for allergic disease is a misnomer. BMJ. 2014;26:g5267.CrossRef
41.
go back to reference Tung HY, Landers C, Li E, Porter P, Kheradmand F, Corry DB. Allergen-encoded signals that control allergic responses. Curr Opin Allergy Clin Immunol. 2016;16:51–8.CrossRefPubMedPubMedCentral Tung HY, Landers C, Li E, Porter P, Kheradmand F, Corry DB. Allergen-encoded signals that control allergic responses. Curr Opin Allergy Clin Immunol. 2016;16:51–8.CrossRefPubMedPubMedCentral
42.
go back to reference Pfeffer PE, Corrigan CJ. An Imbalance between Proteases and Endogenous Protease Inhibitors in Eosinophilic Airway Disease. Am J Respir Crit Care Med. 2017;195:707–8.CrossRefPubMed Pfeffer PE, Corrigan CJ. An Imbalance between Proteases and Endogenous Protease Inhibitors in Eosinophilic Airway Disease. Am J Respir Crit Care Med. 2017;195:707–8.CrossRefPubMed
43.
go back to reference Fritscher LG, Marras TK, Bradi AC, Fritscher CC, Balter MS, Chapman KR. Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case–control study. Chest. 2011;139:23–7.CrossRefPubMed Fritscher LG, Marras TK, Bradi AC, Fritscher CC, Balter MS, Chapman KR. Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case–control study. Chest. 2011;139:23–7.CrossRefPubMed
44.
go back to reference Toulza F, Tsang L, Ottenhoff TH, Brown M, Dockrell HM. Mycobacterium tuberculosis-specific CD4+ T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB. Eur J Immunol. 2016;46:752–61.CrossRefPubMed Toulza F, Tsang L, Ottenhoff TH, Brown M, Dockrell HM. Mycobacterium tuberculosis-specific CD4+ T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB. Eur J Immunol. 2016;46:752–61.CrossRefPubMed
45.
go back to reference Lombardi C, Passalacqua G. Eosinophilia and diseases: clinical revision of 1862 cases. Arch Intern Med. 2003;163:1371–3.CrossRefPubMed Lombardi C, Passalacqua G. Eosinophilia and diseases: clinical revision of 1862 cases. Arch Intern Med. 2003;163:1371–3.CrossRefPubMed
Metadata
Title
An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation
Authors
Paul E. Pfeffer
Susan Hopkins
Ian Cropley
David M. Lowe
Marc Lipman
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2017
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-017-0579-9

Other articles of this Issue 1/2017

Respiratory Research 1/2017 Go to the issue